{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T01:12:15Z","timestamp":1782522735312,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,18]],"date-time":"2023-02-18T00:00:00Z","timestamp":1676678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004772","name":"Natural Science Foundation of Ningxia Province","doi-asserted-by":"publisher","award":["2021AAC03399"],"award-info":[{"award-number":["2021AAC03399"]}],"id":[{"id":"10.13039\/501100004772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Metastasis"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s10585-023-10199-6","type":"journal-article","created":{"date-parts":[[2023,2,19]],"date-time":"2023-02-19T06:24:15Z","timestamp":1676787855000},"page":"149-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Sufentanil combined with parecoxib sodium inhibits proliferation and metastasis of HER2-positive breast cancer cells and regulates epithelial-mesenchymal transition"],"prefix":"10.1007","volume":"40","author":[{"given":"Sunmian","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuexin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,18]]},"reference":[{"issue":"3","key":"10199_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"Cancer J Clin"},{"issue":"10","key":"10199_CR2","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1200\/OP.21.00172","volume":"17","author":"O Mart\u00ednez-S\u00e1ez","year":"2021","unstructured":"Mart\u00ednez-S\u00e1ez O, Prat A (2021) Current and future management of HER2-Positive metastatic breast Cancer. JCO Oncol Pract 17(10):594\u2013604. https:\/\/doi.org\/10.1200\/OP.21.00172","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"10199_CR3","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3322\/caac.21498","volume":"68","author":"DA Mahvi","year":"2018","unstructured":"Mahvi DA, Liu R, Grinstaff MW, Colson YL, Raut CP (2018) Local Cancer recurrence: the Realities, Challenges, and Opportunities for New Therapies. Cancer J Clin 68(6):488\u2013505. https:\/\/doi.org\/10.3322\/caac.21498","journal-title":"Cancer J Clin"},{"key":"10199_CR4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/1479-5876-10-205","volume":"10","author":"J Galon","year":"2012","unstructured":"Galon J, Pages F, Marincola FM et al (2012) Cancer classification using the immunoscore: a worldwide task force. J translational Med 10:205. https:\/\/doi.org\/10.1186\/1479-5876-10-205","journal-title":"J translational Med"},{"issue":"6","key":"10199_CR5","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1002\/ijc.26448","volume":"130","author":"AN Tavare","year":"2012","unstructured":"Tavare AN, Perry NJ, Benzonana LL, Takata M, Ma D (2012) Cancer recurrence after surgery: direct and indirect effects of anesthetic agents. Int J Cancer 130(6):1237\u20131250. https:\/\/doi.org\/10.1002\/ijc.26448","journal-title":"Int J Cancer"},{"issue":"6","key":"10199_CR6","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1213\/ANE.0b013e3181de0ab6","volume":"110","author":"A Gottschalk","year":"2010","unstructured":"Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M (2010) Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110(6):1636\u20131643. https:\/\/doi.org\/10.1213\/ANE.0b013e3181de0ab6","journal-title":"Anesth Analg"},{"key":"10199_CR7","doi-asserted-by":"publisher","first-page":"792290","DOI":"10.3389\/fonc.2021.792290","volume":"11","author":"CA Scroope","year":"2021","unstructured":"Scroope CA, Singleton Z, Hollmann MW, Parat MO (2021) Opioid receptor-mediated and non-opioid receptor-mediated roles of opioids in Tumour Growth and Metastasis. Front Oncol 11:792290. https:\/\/doi.org\/10.3389\/fonc.2021.792290","journal-title":"Front Oncol"},{"issue":"6","key":"10199_CR8","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1213\/ANE.0b013e3181d8d183","volume":"110","author":"JG Bovill","year":"2010","unstructured":"Bovill JG (2010) Surgery for cancer: does anesthesia matter? Anesth Analg 110(6):1524\u20131526. https:\/\/doi.org\/10.1213\/ANE.0b013e3181d8d183","journal-title":"Anesth Analg"},{"issue":"2","key":"10199_CR9","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2217\/pmt-2021-0070","volume":"12","author":"MF Ramirez","year":"2022","unstructured":"Ramirez MF, Rangel FP, Cata JP (2022) Perioperative pain, analgesics and cancer-related outcomes: where do we stand? Pain Manage 12(2):229\u2013242. https:\/\/doi.org\/10.2217\/pmt-2021-0070","journal-title":"Pain Manage"},{"issue":"4","key":"10199_CR10","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrclinonc.2014.224","volume":"12","author":"M Horowitz","year":"2015","unstructured":"Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S (2015) Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol 12(4):213\u2013226. https:\/\/doi.org\/10.1038\/nrclinonc.2014.224","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10199_CR11","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1002\/jso.26836","volume":"125","author":"A Zorrilla-Vaca","year":"2022","unstructured":"Zorrilla-Vaca A, Ripolles-Melchor et al (2022) Association between enrollment in an enhanced recovery program for colorectal cancer surgery and long-term recurrence and survival. J Surg Oncol 125(8):1269\u20131276. https:\/\/doi.org\/10.1002\/jso.26836","journal-title":"J Surg Oncol"},{"issue":"6","key":"10199_CR12","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s00595-013-0517-5","volume":"43","author":"Y Saito","year":"2013","unstructured":"Saito Y, Shimada et al (2013) Regulatory T cells in the blood: a new marker of surgical stress. Surg Today 43(6):608\u2013612. https:\/\/doi.org\/10.1007\/s00595-013-0517-5","journal-title":"Surg Today"},{"issue":"1","key":"10199_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40545-021-00325-8","volume":"14","author":"H Shi","year":"2021","unstructured":"Shi H, Chen X, Liu X, Zhu H, Yu F, Ung C, Chan WS, Hu H, Han S (2021) National drug utilization trend of analgesics in China: an analysis of procurement data at 793 public hospitals from 2013 to 2018. J Pharm Policy Pract 14(1):45. https:\/\/doi.org\/10.1186\/s40545-021-00325-8","journal-title":"J Pharm Policy Pract"},{"issue":"12","key":"10199_CR14","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1016\/j.clinthera.2019.10.002","volume":"41","author":"L Martinez","year":"2019","unstructured":"Martinez L, Ekman E, Nakhla N (2019) Perioperative Opioid-sparing strategies: utility of conventional NSAIDs in adults. Clin Ther 41(12):2612\u20132628. https:\/\/doi.org\/10.1016\/j.clinthera.2019.10.002","journal-title":"Clin Ther"},{"issue":"6","key":"10199_CR15","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.3892\/ol.2019.10997","volume":"18","author":"H Jiang","year":"2019","unstructured":"Jiang H, Wang H, Zou W, Hu Y, Chen C, Wang C (2019) Sufentanil impairs autophagic degradation and inhibits cell migration in NCI-H460 in vitro. Oncol Lett 18(6):6829\u20136835. https:\/\/doi.org\/10.3892\/ol.2019.10997","journal-title":"Oncol Lett"},{"issue":"1","key":"10199_CR16","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12871-018-0622-5","volume":"18","author":"J Chipollini","year":"2018","unstructured":"Chipollini J, Alford et al (2018) Epidural anesthesia and cancer outcomes in bladder cancer patients: is it the technique or the medication? A matched-cohort analysis from a tertiary referral center. BMC Anesthesiol 18(1):157. https:\/\/doi.org\/10.1186\/s12871-018-0622-5","journal-title":"BMC Anesthesiol"},{"issue":"12","key":"10199_CR17","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/EJA.0b013e32834b7d9a","volume":"28","author":"P Forget","year":"2011","unstructured":"Forget P, Tombal et al (2011) Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol 28(12):830\u2013835. https:\/\/doi.org\/10.1097\/EJA.0b013e32834b7d9a","journal-title":"Eur J Anaesthesiol"},{"issue":"3","key":"10199_CR18","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1111\/jep.13256","volume":"26","author":"RD Wang","year":"2020","unstructured":"Wang RD, Zhu JY, Zhu Y, Ge YS, Xu GL, Jia WD (2020) Perioperative analgesia with parecoxib sodium improves postoperative pain and immune function in patients undergoing hepatectomy for hepatocellular carcinoma. J Eval Clin Pract 26(3):992\u20131000. https:\/\/doi.org\/10.1111\/jep.13256","journal-title":"J Eval Clin Pract"},{"issue":"3","key":"10199_CR19","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/cpdd.818","volume":"10","author":"Z Wan","year":"2021","unstructured":"Wan Z, Chu C, Zhou R, Que B (2021) Effects of Oxycodone Combined with Flurbiprofen Axetil on Postoperative Analgesia and Immune function in patients undergoing Radical Resection of Colorectal Cancer. Clin Pharmacol drug Dev 10(3):251\u2013259. https:\/\/doi.org\/10.1002\/cpdd.818","journal-title":"Clin Pharmacol drug Dev"},{"issue":"10","key":"10199_CR20","first-page":"1567","volume":"27","author":"X Feng","year":"2007","unstructured":"Feng X, Lin SQ, Chen Y, Wu XJ (2007) Nan fang yi ke da xue xue bao = Journal. South Med Univ 27(10):1567\u20131569","journal-title":"South Med Univ"},{"issue":"6","key":"10199_CR21","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.hbpd.2018.08.001","volume":"17","author":"JG Guo","year":"2018","unstructured":"Guo JG, Zhao et al (2018) Novel multimodal analgesia regimen improves post-TACE pain in patients with hepatocellular carcinoma. Hepatobiliary & pancreatic diseases international: HBPD INT 17(6):510\u2013516. https:\/\/doi.org\/10.1016\/j.hbpd.2018.08.001","journal-title":"Hepatobiliary & pancreatic diseases international: HBPD INT"},{"issue":"1","key":"10199_CR22","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1158\/0008-5472.CAN-11-4208","volume":"73","author":"CW Doornebal","year":"2013","unstructured":"Doornebal CW, Klarenbeek et al (2013) A preclinical mouse model of invasive lobular breast cancer metastasis. Cancer Res 73(1):353\u2013363. https:\/\/doi.org\/10.1158\/0008-5472.CAN-11-4208","journal-title":"Cancer Res"},{"key":"10199_CR23","doi-asserted-by":"publisher","unstructured":"Bundscherer A, Malsy et al (2015) Effects of ropivacaine, bupivacaine and sufentanil in colon and pancreatic cancer cells in vitro. Pharmacol Res 95\u201396. https:\/\/doi.org\/10.1016\/j.phrs.2015.03.017","DOI":"10.1016\/j.phrs.2015.03.017"},{"issue":"16","key":"10199_CR24","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.3390\/ijms20163902","volume":"20","author":"T Ferreira","year":"2019","unstructured":"Ferreira T, Campos et al (2019) The Cyclooxigenase-2 inhibitor parecoxib prevents epidermal dysplasia in HPV16-Transgenic mice: Efficacy and Safety Observations. Int J Mol Sci 20(16):3902. https:\/\/doi.org\/10.3390\/ijms20163902","journal-title":"Int J Mol Sci"},{"issue":"1S Suppl 2","key":"10199_CR25","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1097\/TA.0000000000001833","volume":"85","author":"L Xiang","year":"2018","unstructured":"Xiang L, Klemcke HG, Wienandt NA, Ryan KL, Hinojosa-Laborde C (2018) A novel rat model of extremity trauma for prehospital pain management research. J trauma acute care Surg 85(1S Suppl 2):S49\u2013S56. https:\/\/doi.org\/10.1097\/TA.0000000000001833","journal-title":"J trauma acute care Surg"},{"key":"10199_CR26","doi-asserted-by":"publisher","unstructured":"Tang H, Li C, Wang Y, Deng L (2021) Sufentanil Inhibits the Proliferation and Metastasis of Esophageal Cancer by Inhibiting the NF-\u03baB and Snail Signaling Pathways. Journal of oncology, 2021, 7586100. https:\/\/doi.org\/10.1155\/2021\/7586100","DOI":"10.1155\/2021\/7586100"},{"issue":"1","key":"10199_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s12871-020-01129-0","volume":"20","author":"Y Peng","year":"2020","unstructured":"Peng Y, Yang et al (2020) Sufentanil postoperative analgesia reduce the increase of T helper 17 (Th17) cells and FoxP3 + regulatory T (Treg) cells in rat hepatocellular carcinoma surgical model: a randomised animal study. BMC Anesthesiol 20(1):212. https:\/\/doi.org\/10.1186\/s12871-020-01129-0","journal-title":"BMC Anesthesiol"},{"issue":"3","key":"10199_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1242\/bio.021410","volume":"6","author":"LY Li","year":"2017","unstructured":"Li LY, Xiao J, Liu Q, Xia K (2017) Parecoxib inhibits glioblastoma cell proliferation, migration and invasion by upregulating miRNA-29c. Biology open 6(3):311\u2013316. https:\/\/doi.org\/10.1242\/bio.021410","journal-title":"Biology open"},{"issue":"2","key":"10199_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s10549-020-06089-0","volume":"186","author":"JM Mondaca","year":"2021","unstructured":"Mondaca JM, Guijarro A, Flamini MI, Sanchez AM (2021) Heregulin-induced cell migration is prevented by trastuzumab and trastuzumab-emtansine in HER2 + breast cancer. Breast Cancer Res Treat 186(2):363\u2013377. https:\/\/doi.org\/10.1007\/s10549-020-06089-0","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"10199_CR30","doi-asserted-by":"publisher","first-page":"e0201370","DOI":"10.1371\/journal.pone.0201370","volume":"13","author":"HM Duivenvoorden","year":"2018","unstructured":"Duivenvoorden HM, Spurling A, O\u2019Toole SA, Parker BS (2018) Discriminating the earliest stages of mammary carcinoma using myoepithelial and proliferative markers. PLoS ONE 13(7):e0201370. https:\/\/doi.org\/10.1371\/journal.pone.0201370","journal-title":"PLoS ONE"},{"issue":"5","key":"10199_CR31","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","volume":"12","author":"SJ Yang","year":"2021","unstructured":"Yang SJ, Wang et al (2021) Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/\u03b2-catenin (cyclin D1) axis. Cell Death Dis 12(5):420. https:\/\/doi.org\/10.1038\/s41419-021-03680-1","journal-title":"Cell Death Dis"},{"issue":"2","key":"10199_CR32","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1158\/0008-5472.CAN-20-1871","volume":"81","author":"SP Kolapalli","year":"2021","unstructured":"Kolapalli SP, Sahu et al (2021) RNA-Binding RING E3-Ligase DZIP3\/hRUL138 stabilizes cyclin D1 to Drive Cell-Cycle and Cancer Progression. Cancer Res 81(2):315\u2013331. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-1871","journal-title":"Cancer Res"},{"key":"10199_CR33","doi-asserted-by":"publisher","unstructured":"Zhu X, Li J, Ning H, Yuan Z, Zhong Y, Wu S, Zeng JZ (2021) \u03b1-Mangostin induces apoptosis and inhibits metastasis of breast Cancer cells via regulating RXR\u03b1-AKT signaling pathway. 12:739658. Frontiers in pharmacologyhttps:\/\/doi.org\/10.3389\/fphar.2021.739658","DOI":"10.3389\/fphar.2021.739658"},{"issue":"37","key":"10199_CR34","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1038\/s41388-021-01958-4","volume":"40","author":"F Seto-Tetsuo","year":"2021","unstructured":"Seto-Tetsuo F, Arioka et al (2021) DIF-1 inhibits growth and metastasis of triple-negative breast cancer through AMPK-mediated inhibition of the mTORC1-S6K signaling pathway. Oncogene 40(37):5579\u20135589. https:\/\/doi.org\/10.1038\/s41388-021-01958-4","journal-title":"Oncogene"},{"issue":"6","key":"10199_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3390\/ph15060651","volume":"15","author":"C Saponaro","year":"2022","unstructured":"Saponaro C, Fanizzi et al (2022) Downstream Signaling of Inflammasome Pathway affects patients\u2019 outcome in the context of distinct molecular breast Cancer subtypes. Pharmaceuticals (Basel Switzerland) 15(6):651. https:\/\/doi.org\/10.3390\/ph15060651","journal-title":"Pharmaceuticals (Basel Switzerland)"},{"issue":"2","key":"10199_CR36","first-page":"147","volume":"52","author":"C Irawan","year":"2020","unstructured":"Irawan C, Cahyanur R, Lisnawati L, Abdullah M, Yunus RE (2020) The difference in the cyclin D1 expression in Advanced Stage Nasopharyngeal Cancer based on treatment response: a retrospective cohort study. Acta Med Indones 52(2):147\u2013154","journal-title":"Acta Med Indones"},{"issue":"13","key":"10199_CR37","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1158\/1078-0432.CCR-17-3473","volume":"24","author":"M Filipits","year":"2018","unstructured":"Filipits M, Dafni U, Gnant M et al (2018) Association of p27 and cyclin D1 expression and benefit from Adjuvant Trastuzumab Treatment in HER2-Positive early breast Cancer: a TransHERA study. Clin cancer research: official J Am Association Cancer Res 24(13):3079\u20133086. https:\/\/doi.org\/10.1158\/1078-0432.CCR-17-3473","journal-title":"Clin cancer research: official J Am Association Cancer Res"},{"key":"10199_CR38","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.canlet.2021.11.031","volume":"526","author":"Y Du","year":"2022","unstructured":"Du Y, Zhang et al (2022) Hypoxia-induced ebv-circLMP2A promotes angiogenesis in EBV-associated gastric carcinoma through the KHSRP\/VHL\/HIF1\u03b1\/VEGFA pathway. Cancer Lett 526:259\u2013272. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.031","journal-title":"Cancer Lett"},{"issue":"9","key":"10199_CR39","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi H, Ivaska J (2018) Every step of the way: integrins in cancer progression and metastasis. Nat Rev Cancer 18(9):533\u2013548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z","journal-title":"Nat Rev Cancer"},{"key":"10199_CR40","doi-asserted-by":"publisher","first-page":"146927","DOI":"10.1016\/j.gene.2022.146927","volume":"850","author":"M Li","year":"2023","unstructured":"Li M, Yan T, Cai Y, Wei Y, Xie Q (2023) Expression of matrix metalloproteinases and their association with clinical characteristics of solid tumors. Gene 850:146927. https:\/\/doi.org\/10.1016\/j.gene.2022.146927","journal-title":"Gene"},{"issue":"3","key":"10199_CR41","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C (2019) EMT Transition States during Tumor Progression and Metastasis. Trends Cell Biol 29(3):212\u2013226. https:\/\/doi.org\/10.1016\/j.tcb.2018.12.001","journal-title":"Trends Cell Biol"},{"issue":"2\u20133","key":"10199_CR42","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s10555-018-9752-y","volume":"37","author":"D Tong","year":"2018","unstructured":"Tong D, Liu et al (2018) The roles of the COX2\/PGE2\/EP axis in therapeutic resistance. Cancer Metastasis Rev 37(2\u20133):355\u2013368. https:\/\/doi.org\/10.1007\/s10555-018-9752-y","journal-title":"Cancer Metastasis Rev"}],"container-title":["Clinical & Experimental Metastasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10199-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10585-023-10199-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10585-023-10199-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T00:09:29Z","timestamp":1681862969000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10585-023-10199-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,18]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["10199"],"URL":"https:\/\/doi.org\/10.1007\/s10585-023-10199-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1853361\/v1","asserted-by":"object"}]},"ISSN":["0262-0898","1573-7276"],"issn-type":[{"value":"0262-0898","type":"print"},{"value":"1573-7276","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,18]]},"assertion":[{"value":"13 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}